Effect of setting a maximum milking time,from peak lactation,on production,milking time and udder health

Abstract

AIM: To examine the effect of setting a maximum milking time, from peak lactation until drying-off, on production, duration of milking, and udder health of dairy cows.

METHODS: Forty cows were assigned in twin-pairs to be either milked until cups were removed at a milk flow-rate threshold of 0.35 kg/minute (Control), or until cups were removed at a milk flow-rate threshold of 0.35 kg/minute, or maximum time, whichever came first (MaxT). The maximum time was set by determining the milking time of the 70th percentile cow when ranked from fastest to slowest, irrespective of yield. The milking routine was typical of that practised on dairy farms in New Zealand, and involved no pre-milking preparation. The study began at peak lactation (68 (SD 7) days in milk; DIM) and continued for 26 weeks. Duration of milking and milk yield were measured for each milking. Composition of milk was determined from weekly herd tests, and milk quality from fortnightly somatic cell counts (SCC). Completeness of milking and teat condition were assessed during the study. The bacterial status of quarter milk samples was determined at the beginning and end of the study, and all treated cases of clinical mastitis recorded. ANOVA was used to examine the effect of treatment group on variables of interest.

RESULTS: Total milk, fat and protein yields during the study period did not differ between treatments. On average, 30.3% of the morning and 27.6% of the afternoon milkings of MaxT cows reached the maximum time at which cups were removed, and were therefore shortened. While the average milking time of the slowest-milking cow was longer for the Control compared with MaxT group in Weeks 1–18, the average milking time did not differ between treatments. There was no difference in overall SCC, and the incidence of clinical mastitis, or the percentage of infected quarters at drying-off, was similar for the MaxT and Control cows.

CONCLUSION: The results show that setting a maximum milking time can reduce the milking time of slower-milking cows in a herd without compromising overall herd production and udder health.

CLINICAL RELEVANCE: Although the numbers of cows in the study were small there was no evidence of a major increase in SCC, or subclinical or clinical mastitis when a maximum milking time was set for slower-milking cows.     

A large scale mastitis control programme in Somerset.

The results of a mastitis control programme operated in south west England for three years are given. Farmers participating in the full mastitis control group agreed to treat each cow at drying off with 500 mg benzathine cloxacillin in each quarter, to have their milking machines tested and to correct any faults, and to practise teat dipping. Data covering cell counts, milk production, milk quality and clinical mastitis, were assessed from herds taking part in the programme. Cell counts were analysed from all 507 herds taking part in the programme. Milk production records for the full mastitis control group (188 herds) over a three year period are discussed, and these results compared with milk production figures from Milk Marketing Board records from herds in the south west of England which were carrying out no specific mastitis control programme. The milk quality data compare the findings in 159 herds in the full mastitis control programme with those in 247 herds in the partial and no mastitis control groups. Cases of clinical mastitis during the three year period were recorded in 73 herds in the full mastitis control group. The problems of applying the control routines are presented with observations on clinical mastitis, bulk milk cell count, milk production and milk quality. After three years, herds in the programme had on average increased milk production by 75 gallons a cow, achieved a 14.6 per cent reduction in the incidence of clinical mastitis, and improved the milk total solids percentage by one milk quality payment class.     

Somatic cell counts, mastitis and milk production in selected Ontario dairy herds.

Somatic cell counts were performed monthly on bulk tank milk samples for all producers in the Ontario counties of Hastings, Lennox/Addington and Prince Edward throughout 1978 and 1979. Other data were obtained via a structured questionnaire and from the records of the Ontario Milk Marketing Board. Many producers have not adopted practices that have been advocated for the integrated control of mastitis. For example, 43.3% of producers surveyed used single service paper towels, 63.3% regularly used teat dip and 56.5% dry cow therapy. The mean of the average monthly somatic cell count for all producers for 1978 was 621.1 x 10(3) cells/mL. This latter value was used to divide the producers into case (higher than average) and control (lower than average) groups. Control herds averaged 95.9 liters more shipped milk per cow per month than case herds. Milk from control herds averaged 0.22 percentage points higher than case herds for each of average fat and lactose, and 0.16 percentage points higher for protein. The linear regression of monthly shipped milk on the respective monthly bulk tank somatic cell count indicated a loss of 13.26 L/cow/month for each 100,000 increase in somatic cell count.     

Intramammary infections and risk factors for clinical mastitis in herds with low somatic cell counts in bulk milk

Ten herds with low somatic cell counts in bulk milk had an incidence of clinical mastitis of only 2.2 per 100 cows whereas 10 other herds with similarly low cell counts had an incidence of 53.6 per 100 cows. The major pathogens in the herds with a high incidence were Escherichia coli, Streptococcus uberis, Staphylococcus aureus and the coagulase-negative staphylococci. The percentage of uninfected quarters in the herds with a high incidence of clinical mastitis was 21.4 per cent compared with 12.2 per cent in the herds with a low incidence of clinical mastitis. The prevalence of coagulase-negative staphylococci, Corynebacterium bovis and Micrococcus species was higher in the herds with a low incidence of clinical mastitis. There was a significant linear relationship between the percentage of uninfected quarters and the incidence of clinical mastitis in the herds with a high incidence of clinical mastitis. In herds with a low incidence of clinical mastitis significantly less teat disinfection after milking was practised. The results suggest that infections with minor pathogens tend to protect cows against mastitis, and that teat disinfection after milking may increase the percentage of uninfected quarters and lead to an increased risk of clinical mastitis in herds with low somatic cell counts in bulk milk.     

A case-control study of Nocardia mastitis in Ontario dairy herds

A case-control study was conducted to identify milking hygiene and udder therapy factors associated with a diagnosis of Nocardia mastitis in dairy herds from which milk samples are submitted to the Ontario Ministry of Agriculture and Food, Veterinary Laboratory Services, Guelph laboratory. The data were collected by telephone interview from 31 case and 31 control herds.

After analytical control for confounders, blanket dry cow therapy and a dry cow antibiotic product were associated with a diagnosis of Nocardia mastitis in a herd, whereas another dry cow antibiotic product had a sparing effect.

In comparison to mastitis pathogens susceptible to dry cow antibiotic therapy, Nocardia species were isolated infrequently from milk specimens submitted to the Guelph mastitis laboratory.

     

Economic effects of mastitis prevention strategies for dairy producers

For efficient disease management in dairy production, the influence of disease prevention strategies on farm profitability must be known. A survey of mastitis control practices, milking machine function and maintenance, and cow environmental conditions was conducted with 406 dairy producers on the Michigan Dairy Herd Improvement-somatic cell counting program responding. These survey data, in conjunction with Dairy Herd Improvement production data, were used to develop a model estimating the marginal value products of mastitis control practices. Lost milk production associated with increased somatic cell count was calculated for each herd. Mastitis control practices, milking machine function and maintenance, and cow environmental conditions were used as independent variables in an analysis of covariance model with lost milk production as the dependent variable. Variables significant in explaining changes in production from increased somatic cell count were the use of teat dip, use of sanitizer in the wash water, milking cow bedding, summer nonlactating cow housing, summer calving locations, type of regulator, alternating pulsation, and rolling herd average milk production. The marginal value product (change in revenues received) from the use of iodine, chlorhexidine, and quaternary ammonium-type teat dips were $13.79, $16.09, and $22.17/cow/year, respectively, and these changes were statistically significant. However, sanitizer in the wash water was associated with a decrease in production. Management practices that have previously been shown to be economical and did not appear in the final model included nonlactating cow therapy and single-use paper towels.     

An investigation of risk factors for nocardial mastitis in central Alberta dairy herds

A case-control study was undertaken during the summer of 1989 in central Alberta dairy herds to identify independent predictors of nocardial mastitis. Thirty-seven herds with nocardial mastitis were matched with control herds based on herd size, milk production, and enrolment in Alberta Dairy Herd Improvement Services. Control herds were considered free of nocardial mastitis based on negative cultures of four weekly bulk tank milk samples and one composite milk sample collected during the same period from each lactating cow in the herd. A detailed questionnaire on herd management was completed during farm visits. The use of blanket dry cow therapy was not found to be a risk factor for nocardial mastitis. Dry cow therapy with intramammary products containing neomycin and the use of multidose vials of dry cow medications were the only predisposing factors identified as being significantly associated with nocardial mastitis in central Alberta dairy herds. Use of neomycin as a dry cow therapy increased the odds of nocardial mastitis occurring in these dairy herds by 169 times.     

A comparison of production and management between Wisconsin organic and conventional dairy herds

An observational study was conducted in Wisconsin to compare production and management on organic and conventional dairy farms. Thirty organic dairy herds, where antimicrobials are rarely used for calves and never used for cows, were compared with 30 neighboring conventional dairy farms on which antimicrobials were routinely used for animals of all ages. A seven-page questionnaire regarding milk production, milking practices, housing, incidence of the major dairy diseases and medical treatments was used to assess management and production during 2000-2001. Body condition scores (BCS) of lactating cows and environmental and animal sanitation scores (EASS) were also collected on each of two occasions. The organic herds had significantly fewer cattle than did the conventional herds (P=0.017). The average daily milk production per cow in organic dairy herds (20.2 kg/day) was lower than that of conventional herds (23.7 kg/day). The incidence of clinical mastitis (CM) on organic farms (28 cases per 100 cow-years at risk) was not statistically different from that of on conventional farms (32 cases per 100 cow-years at risk). No significant difference in bulk tank somatic cell count (BTSCC) was observed between organic farms (262,000 cells/ml) and conventional farms (285,000 cells/ml). The average annual cull rate was 18.0 cases per 100 cow-years for the conventional farms and 17.2 for the organic farms (P=0.426). Our paired t-test results indicated significantly higher parasite burden on organic dairy farms; however, no significant difference between the two farm types when controlling for season (March and September), grazing intensity (no grazing, little grazing, grazing with access to housing and grazing only) and herd average milk production per cow. There was little evidence of other fundamental differences between the two farm types in other management and production parameters.     

Risk factors associated with the incidence of veterinary-treated clinical mastitis in Swedish dairy herds with a high milk yield and a low prevalence of subclinical mastitis

We conducted a case-control study to investigate factors associated with the incidence rate of veterinary-treated clinical cases of mastitis (IRVTCM) in Swedish dairy herds with the overall objective to reduce the incidence of clinical mastitis (CM) and excessive use of antibiotics. Herds with documented high milk yield, low prevalence of subclinical mastitis and high (27.3-67.5 cases/100-cow years=case) or low (0.0-10.8 cases/100-cow years=control) IRVTCM were selected for this study. One hundred and fifty-eight herds participated. Logistic-regression models were used to assess statistically significant risk factors associated with a high or low IRVTCM. HI-herd farmers more often contacted a veterinarian for treatment of a cow with CM as soon as the milk appearance was altered, compared to LO-herd farmers that more often waited until the general condition of a cow was altered. HI-herd farmers also treated more cows due to high somatic-cell counts during lactation and/or at drying off. There were more high-yielding cows with dirty lower hind-legs, a higher percentage of first-parity cows and a higher incidence of veterinary-treated teat injuries in HI-herds. HI-herd farmers had their cows claw-trimmed more than once per year, compared to LO-herd farmers that had their cows claw-trimmed only once per year, and the condition of silage storage at HI-farms more often had one or more remarks. LO-herds consisted more often of cows of the Swedish Red and White breed, and their roughage diet was more often complemented with only commercial concentrates compared to HI-herds that more often fed grain in combination with commercial concentrates. The herds participating in this study were all well managed herds, and the attitude towards treatment and production seemed to influence the IRVTCM more than environmental factors.     

Risk factors associated with the incidence rate of clinical mastitis in smallholder dairy cows in the Dar es Salaam region of Tanzania

Smallholder dairy herds around the Dar es Salaam region of Tanzania supply 86% of raw milk consumed by the city dwellers. Previous studies have indicated that clinical mastitis is an important disease affecting smallholder dairy cows and an 18-month questionnaire-based longitudinal field-study was conducted between July 2003 and March 2005 to elucidate risk factors associated with the incidence. A total of 6057 quarter-level observations from 317 lactating cows on 87 randomly selected smallholder dairy herds were analysed at the quarter and cow level using logistic and Poisson regression models, respectively. At the quarter level, the average incidence rate of clinical mastitis was 38.4 cases per 100 quarter-years at risk whereas at the cow level the incidence rate was 43.3 cases per 100 cow-years at risk. The incidence was significantly (P< or =0.001) associated with cow factors (body condition score, parity, stage of lactation, and udder consistency), housing (floor type) conditions and milking (cow and udder preparation) practices. It was concluded that the extrapolation of the classic ten-point mastitis control plan into smallholder dairy herds should be undertaken cautiously. An integrated approach to dairy extension should focus more on the creation of mastitis awareness among smallholder producers and on the improvement of animal nutrition and reproduction indices-factors that may also have a direct impact on milk yield.     

Within herd comparison of teat dipping and dry cow therapy with only selective dry cow therapy in six herds

A within herd comparison of teat dipping and dry cow therapy (full treatment) with only selective dry cow therapy (partial treatment) was carried out in six commercial dairy herds for a two year period. In four herds, the incidence of clinical mastitis was 2 to 12 per cent higher in the partial treatment group. In another herd, in which the pattern of clinical mastitis isolates was unusual in that minor pathogens were isolated from 30 per cent of mastitis cases, the incidence was 43 per cent higher in the partial treatment group. In the remaining herd the incidence was 10 percent higher in the full treatment group. Streptococcus uberis mastitis was more common in the partial treatment groups of five herds; coliform mastitis was more common in the full treatment groups of two herds and similar in both groups in the other herds. High rates of coliform mastitis were associated with poor herd environmental conditions but this was not true for Strep uberis mastitis. Rates of staphylococcus aureus and Strep dysgalactiae mastitis were low in all herds. The level of major pathogen infection in cows completing the trial in all herds increased in the partial treatment group from 5 per cent of quarters at the start to 12 per cent at the finish of the trial. In the full treatment group, however, there was only a small increase in this level. In contrast, levels of Corynebacterium bovis infection increased by 17 per cent in both treatment groups. Continued use of teat dipping and dry cow therapy was associated with a higher rate of coliform mastitis in two of the three herds where there were poor standards of hygiene and husbandry.     

Costs associated with selected preventive practices and with episodes of clinical mastitis in nine herds with low somatic cell counts

Nine dairy herds (mean size, 149 cows) with bulk-tank milk somatic cell counts of less than 300,000 cells/ml and greater than 80% of cows with Dairy Herd Improvement Association linear somatic cell counts less than or equal to 4 were selected for study. Each herd was monitored for 12 consecutive months. Duplicate quarter-milk specimens were collected from each cow for bacteriologic culturing at beginning of lactation, cessation of lactation, and at the time of each clinical episode of mastitis. Streptococcus agalactiae was never isolated and Staphylococcus aureus was isolated from less than 1% of all quarters. There were 554 episodes of clinical mastitis. During the year of study, the incidence rate of clinical mastitis varied from 15.6 to 63.7% of cows among the 9 herds. Mean costs per cow per year in herd for mastitis prevention were: $10 for paper towels, $3 for nonlactating cow treatment, and $10 for teat disinfectants. Mean cost associated with clinical mastitis was $107/episode. Approximately 84% ($90) of the costs attributed to a clinical episode were associated with decreased milk production and nonsalable milk. Costs of medication and professional veterinary fees per clinical episode varied significantly among the 9 herds. Three of the herds did not have a veterinarian treat a clinical episode of mastitis during the year of study even though 2 of these herds had the first and third highest incidence rates of clinical mastitis. When calculated on a per cow in herd basis, mean costs of $40/cow/year were attributed to clinical mastitis.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effect of dry period length on the effect of an intramammary teat sealant on the risk of mastitis in cattle treated with antibiotics at drying off

AIM: The aim of this study was to evaluate, under farm conditions, the use of a teat sealant in addition to whole herd dry cow antibiotic therapy on the risk of clinical mastitis in dairy cattle at pasture, and to evaluate the impact of dry period length on that risk and the impact of the teat sealant on that risk.

METHODS: Dairy cows in three herds which used routine whole herd antibiotic therapy were randomly assigned to receive either treatment with an internal teat sealant (n=322) or no additional treatment (n=313) at drying-off between March and May 2010. All clinical mastitis cases during the dry period and to the end of the subsequent lactation were recorded by farm staff; factors affecting risk of clinical mastitis were then analysed using a Cox proportional hazards model.

RESULTS: Median duration of the dry period was 112 days with >25% of cows having a dry period >130 days. The incidence risk of mastitis during lactation for cows treated with teat sealant was 9.9 (95% CI=6.9–13.7) cases per 100 cows compared with 17.9 (95% CI=13.8–22.6) cases per 100 cows for cows treated with antibiotic alone. The addition of a teat sealant to dry cow antibiotic therapy decreased the risk of clinical mastitis only in the first 33 days after calving (Hazard risk 0.24 (95% CI=0.12–0.48)). Length of dry period did not significantly affect the risk of clinical mastitis, or the effect of adding teat sealant to dry cow antibiotic therapy on the risk of clinical mastitis.

CONCLUSIONS: In these herds where, based on the mastitis history, whole herd antibiotic therapy had been recommended, the use of a teat sealant significantly reduced the risk of clinical mastitis. This effect was limited to the first 33 days after calving; subsequently there was no significant effect of treatment. There was no effect of dry period length on risk of clinical mastitis, nor any significant interaction with treatment.

CLINICAL RELEVANCE: Combination therapy with teat sealant and antibiotic was effective under New Zealand conditions in herds using whole herd antibiotic treatment at drying off. Teat sealant reduced risk of clinical mastitis in cattle with dry periods substantially longer than 100 days, and there was no evidence that this effect changed as dry period length increased.     

A case-control study of Nocardia mastitis in Nova Scotia dairy herds

A case-control study was conducted to identify herd production, housing, and hygienic and therapeutic factors associated with a diagnosis of Nocardia mastitis in dairy herds in Nova Scotia. The data were collected by on-farm interviews with owners of 54 case and 54 control herds.

Logistic regression was used to study risk factors. The use of dry cow products containing neomycin, including two specific dry cow products, was strongly associated with a diagnosis of Nocardia mastitis in a herd. Other factors which increased the risk of Nocardia mastitis were higher levels of production, larger herd size, and a large percentage of cows treated with dry cow products. These results are compared to results from a similar study carried out in Ontario.

     

Mycoplasma mastitis in dairy cattle

The most important characteristics of Mycoplasma mastitis on dairy farms are described, based on two case studies. Clinical symptoms, diagnostics, epidemiology, and a plan of action are presented. In the herds investigated, Mycoplasma mastitis was characterized by multiple affected quarters unresponsive to treatment with antibiotic and/or anti-inflammatory agents. Most striking were a sandy sediment, brown colouring, and rice-like structure of the milk of affected animals. Clinical symptoms differed in the two affected herds. Diagnosis was based on bacteriological investigation of samples of milk and synovial fluid taken from infected cows. Affected animals were culled immediately, and the herds were monitored by repeated testing of bulk milk samples. It was concluded that a consequence of the increasing size of cattle herds in the Netherlands is that subclinical/clinical Mycoplasma mastitis may be diagnosed more frequently than in the past. In the case of Mycoplasma mastitis, farmers and veterinary practitioners are advised to draw up a plan of action together, incorporating aspects such as diagnostics at cow level, direct culling of affected animals, hygiene during milking, including post-milking teat disinfection, and routine monitoring of bulk milk. Unpasteurized milk should not be given to calves.     

Herd management and prevalence of mastitis in dairy herds with high and low somatic cell counts

Thirty-two dairy herds, 16 with low somatic cell counts (LSCC; Dairy Herd Improvement Association 12-month mean herd SCC less than or equal to 150,000 cells/ml) and 16 with high somatic cell counts (HSCC; Dairy Herd Improvement Association 12-month mean herd SCC greater than or equal to 700,000 cells/ml) were evaluated to determine the relationship between the prevalence of mastitis in each herd and each herd's mastitis control and management practices. Once for each herd, duplicate quarter milk samples were collected from the lactating cows, a survey of herd mastitis control, milking hygiene, and management practices of each herd was performed, and milking-machine function was evaluated. Of the 16 herds with LSCC, 2 (12.5%) had Streptococcus agalactiae isolated and 7 (44%) had Staphylococcus aureus isolated. Both organisms were found in all of the herds with HSCC. In herds with LSCC, the mean percentage of quarters infected with Str agalactiae was 0.1%, the mean percentage infected with streptococci other than Str agalactiae was 1.9%, and the mean infected with S aureus was 0.7%. In herds with HSCC, 25.7% of the quarters were infected with Str agalactiae, 3.7% were infected with streptococci other than Str agalactiae, and 7.6% were infected with S aureus. A program of postmilking teat dipping and treatment of all cows at the beginning of the nonlactating period was practiced more frequently in the herds with LSCC (81.3%) than in the herds with HSCC (37.5%). Major differences were not found between the 2 groups of herds in the use of the more common milking hygiene techniques or in the maintenance and functional characteristics of the milking equipment.     

The economic impact of mastitis-control procedures used in Scottish dairy herds with high bulk-tank somatic-cell counts.

We used multiple-regression analysis of field data to quantify the marginal impacts of various mastitis-control procedures on bulk-tank somatic-cell count (BTSCC). Estimates of milk-yield depression and the probability of herds paying a BTSCC penalty due to the presence of subclinical mastitis were made. An assessment of the economic efficiency of mastitis control by high BTSCC producers was also made using a loss-expenditure frontier. Significant interactions were detected between premilking udder-preparation methods (UP) and post-milking teat disinfection (PMTD), and also between the milking system of the herds and both the use of dry-cow therapy (DCT) and a regular milking-machine test (MMT). Udder preparation involving washing was associated with a higher SCC and had a detrimental effect on the efficacy of PMTD. Amongst herds facing a high-BTSCC problem (BTSCC >400,000 cells/ml), herds using PMTD without UP (regardless of the type of milking system), those using DCT (in parlour systems), and those with a parlour system having their milking machines tested obtained returns of Pound Sterling 1.4, Pound Sterling 3.9 and Pound Sterling 1.1, respectively, per Pound Sterling 1 investment in each of these procedures as a result of reductions in milk-yield losses and BTSCC penalties. The minimum total cost of disease within these herds was Pound Sterling 65.50/cow/year (due to Pound Sterling 41.40 revenue losses plus Pound Sterling 24.10 mastitis-control expenditure) attained by herds which had a parlour system and used DCT, MMT and PMTD (without UP). However, the average cost of subclinical mastitis for all high-BTSCC farms was Pound Sterling 100/cow/yr; hence, the difference (pound Sterling 34.50) could be saved by the more-efficient application of mastitis-control procedures.     

Food safety,livestock health,and productivity of a dairy farm following implementation of a certificated Hazard Analysis and Critical Control Points system

This study examined the safety and productivity data analysis of a dairy farm over a 3-year period following the implementation of a Hazard Analysis and Critical Control Point (HACCP) system in 2018. The CCP was “the selection of milking cows” and the critical limit was “the withholding period has passed”. No deviation from the critical limit was observed, the safety of the milk is ensured. In addition, the average daily milk yield per cow increased, while the average number of somatic cells/ml decreased. The number of cows with newly diagnosed mastitis increased, and the product excluded. These results suggest that the HACCP system had a positive effect on milk yield per cow and led to a decrease in somatic cells.     

A descriptive epidemiological study of mastitis in 12 Irish dairy herds

: Factors relating to the occurrence of mastitis were studied on 12 Irish dairy herds with histories of elevated somatic cell count (SCC) and/or increased incidence of clinical mastitis cases. Milk recording data were analysed, housing conditions and calving areas were examined; dry cow therapy, clinical mastitis records, milking technique and aspects of milking machine function were assessed.Herds with a ratio of less than 110 cubicles per 100 cows were more likely to experience environmental mastitis. Herds with inadequate calving facilities, where cows spent prolonged periods on straw bedding, were likely to acquire environmental mastitis. In the majority of the herds, the selection of dry cow therapy lacked adequate planning. The majority of farmers took no action to reduce pain experienced by cows suffering mastitis. Deficiencies in parlour hygiene were evident in all herds experiencing elevation in SCC.     

Prevalence of clinical mastitis in 38 Waikato dairy herds in early lactation

AIM: To determine the prevalence of clinical mastitis in spring-calving dairy herds in the Waikato Region of New Zealand and to identify factors associated with variation in the prevalence of clinical mastitis between herds. METHOD: A total of 799 quarters from 595 dairy cows from 38 dairy herds were diagnosed by herd owners as having clinical mastitis between 8 July and 21 August 1997. Quarters diagnosed with clinical mastitis were sampled for bacterial culture and somatic cell count, and the presence of clots in the milk and the presence of udder oedema were assessed by a technician or veterinarian. RESULTS: Clinical mastitis was diagnosed in an average (+/-s.e.m.) of 9.9% (+/-0.8%, range 0.9-21.4%) of calved cows within the herds. Bacteria were not cultured from an average of 12.4 % (+/- 2.0%, range 0.0-45.5%) of cows and 22.3% (+/- 2.4%, range 0.0-54.0%) of quarters diagnosed as having clinical mastitis. There were significant differences between herds in the proportion of cows diagnosed with mastitis and in the proportion of clinical mastitis cases from which bacteria were not cultured. A decreased prevalence of clinical mastitis (p<0.001) was associated with an increased percentage of the herd treated with dry cow antibiotics. An increased prevalence of clinical mastitis (p<0.0001) was associated with both an increased percentage of cows treated in the previous season with lactating cow antibiotics and an increased percentage of heifers in the herd. Herds that were fed supplements before or during lactation had a higher prevalence of clinical mastitis than herds that were not fed supplements (p<0.001). An increased proportion of quarters diagnosed with clinical mastitis that did not culture bacteria was associated with an increased prevalence of clinical mastitis (p<0.001). The proportion of quarters that the technician or veterinarian found with evidence of clinical mastitis (i.e. a somatic cell count >500,000 cells/ml and the presence of either clots or udder oedema) within a herd was inversely related to the proportion of quarters within a herd from which no bacteria were isolated. CONCLUSION: There was a large variation in the prevalence of clinical mastitis and in the proportion of clinical quarters from which no bacteria were grown between herds. Management factors such as the use of dry cow therapy, feeding regimes and heifer replacement rates all affected the prevalence of clinical mastitis. Herd owners appear to differ in the sensitivity and specificity of their diagnosis of clinical mastitis, with bacteria not isolated from up to 50% of quarters diagnosed with clinical mastitis in some herds. Improvements in the specificity of herd owner diagnosis of clinical mastitis may reduce the use of antibiotics for mastitis during lactation and hence may reduce the risk of antibiotic contamination of milk supplied for human consumption.